5:01 PM ET
8-K
Shareholder Meeting
Decoy Therapeutics Shareholder Meeting
Decoy Therapeutics held a Special Meeting of Stockholders on September 14, 2026, where shareholders approved the issuance of common stock upon the exercise of Series A, B, and C Milestone Warrants. Stockholders also approved an amendment to the Certificate of Incorporation to reduce the number of authorized shares of common stock from 100 million to 90 million.